New parenting program aims to help kids with ADHD – but early days yet

NCT ID NCT07339696

ENROLLING_BY_INVITATION Symptom relief Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a parent training program called the New Forest Parenting Programme for children aged 3-12 who have ADHD or trouble with attention and activity. Researchers want to see if it is practical and acceptable for families in Danish community clinics. The study includes 90 families and will look for early signs of improvement, but it is not designed to prove the program works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: New Forest Parenting Programme (parent training)
What this could lead to: If successful, this could provide a practical, community-based parenting program to help children with ADHD or attention difficulties.
What could go wrong: This is a small, early feasibility study with only 90 participants. It is not designed to prove the program works, and results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD - ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD - ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY ATTENTION CONCENTRATION DIFFICULTY

Contacts and locations

Locations

Forskningsafdelingen - Børne- og Ungdomspsykiatrisk Afdeling, Psykiatrien-Skejby

Aarhus, 8200, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.